New York Mets second baseman Robinson Kano has been suspended for the entire 2021 MLB season after testing positive for the second time in his career for performance-enhancing drugs.
The Mets had acquired Kano from the Seattle Mariners in 2018. In 156 games, he was hit .275 with 23 home games. He entered the season at the age of 38 before stopping.
METS OWNER STEVE COHEN SAYS PLAYERS ARE “MADE”
“We were extremely disappointed to learn of Robinson’s suspension for violating the Major League Baseball Joint Drug Prevention and Treatment Program,” Mets President Sandy Alderson said in a statement. “The violation is very unfortunate for him, the organization, our fans and the sport. Mets fully supports MLB’s efforts to remove performance-enhancing substances from the game. “
According to MLB.com, Cano tested positive for stanozolol. The drug is a “synthetic steroid that is derived from testosterone and has anabolic and androgenic properties,” according to the USDA.
PURCHASE OF APPROVED BILLION METHODS Steve Cohen
Due to the suspension, Kano will lose his entire salary in 2021 MLB.
Kano was to win $ 24 million next season.
Between 2022 and 2023, Cano still has to earn $ 48 million. The Mets, in the sailors’ trade, agreed to cover $ 40 million of that amount, with Seattle taking the rest.
CLICK HERE FOR MORE SPORTS COVERAGE ON FOXBUSINESS.COM
Kano signed a 10-year, $ 240 million contract as a free agent in 2014. He was suspended from 80 games in 2018 for violating the league’s joint drug deal.